Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

Completed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of recurrent metastatic colorectal cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of two different doses of gefitinib in treating patients who have recurrent metastatic colorectal cancer.

Key facts

Study ID

NCT00025350

Run by

Eastern Cooperative Oncology Group

Starts

2001-10-01

Expected to finish

2006-06-01

Last updated by the study team

2013-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Robert H. Lurie Comprehensive Cancer Center, Northwestern University — Chicago, Illinois, United States
• Veterans Affairs Medical Center - Lakeside Chicago — Chicago, Illinois, United States
• CCOP - Central Illinois — Decatur, Illinois, United States
• CCOP - Evanston — Evanston, Illinois, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
• Veterans Affairs Medical Center - New York — New York, New York, United States
• NYU School of Medicine's Kaplan Comprehensive Cancer Center — New York, New York, United States
• CCOP - Merit Care Hospital — Fargo, North Dakota, United States
• Ireland Cancer Center — Cleveland, Ohio, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
• Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus — Nashville, Tennessee, United States
• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
• Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.